DFT Microsystems Closes $3.4 Million in Financing and Ships First Products
DFT Microsystems now poised for growth
Mimetogen Pharmaceuticals Inc. Closes Series A Financing and Completes Exclusive Licensing Agreement with McGill…
Iaculor obtains financing from MSBi Capital
Montreal, Quebec — June 28th 2006
Iaculor Injection Inc. (“Iaculor”), a privately-held company specializing in the development of needle-free drug-delivery…
DFT Microsystems Appoints new President and CEO
Montreal, Canada, February 2, 2006. The board of DFT Microsystems Canada (“DFT”), announces that David Lisk has formally accepted the position of President and CEO of the…